From the Journals

Methadone may shorten NICU stays for neonatal abstinence syndrome


 

FROM THE JOURNAL OF PEDIATRICS

Lengths of stay in the hospital and in the neonatal ICU (NICU) for infants with neonatal abstinence syndrome (NAS) were significantly shorter with methadone treatment, compared with morphine treatment, according to a study published in the Journal of Pediatrics.

Newborn baby in incubator Metin Kiyak/Thinkstock

Veeral N. Tolia, MD, of Baylor University in Dallas, and his associates, gathered data from NICUs participating in the Clinical Data Warehouse and identified 7,667 singleton infants with no congenital abnormalities treated for NAS with either methadone (15%) or morphine (85%) in the first 7 days of life during 2011-2015.

The median hospital length of stay (LOS) was 18 days (interquartile range, 11-30 days) for infants treated with methadone and 23 days (IQR, 16-33 days) for those treated with morphine (P less than .001). The methadone-treated infants also had a shorter median LOS in the NICU than did the morphine-treated infants: 17 days (IQR, 10-29 days) versus 21 days (IQR, 14-36 days; P less than .001). In multivariable analysis, methadone treatment still was associated with a significantly shorter LOS in both cases. The methadone-treated infants also were significantly less likely to require two medications or three or more medications, compared with the morphine treated infants.

Although there was only a modest difference in LOS, Dr. Tolia and associates consider their findings relevant to clinical practice and are important given that “NAS incidence continues to rise and accounts for a substantial portion of health care utilization, including a fourfold increase in the proportion of neonatal hospital costs of all births covered by Medicaid.”

One of the strengths of this study is the size of its cohort; among its weaknesses is that the Clinical Data Warehouse does not include information on symptom severity, indication for starting therapy, or weaning practices.

The researchers declared no conflicts of interest.

SOURCE: Tolia VN et al. J Pediatr. 2018 Sep. doi: 10.1016/j.jpeds.2018.07.061.

Recommended Reading

Spinal muscular atrophy added to newborn screening panel recommendations
MDedge Family Medicine
Preterm birth rate ‘is on the rise again’
MDedge Family Medicine
More deliveries now include opioid use disorder
MDedge Family Medicine
Lung ultrasound predicts need for first-dose surfactant in neonates
MDedge Family Medicine
In the U.S., breastfeeding starts out strong, but drops off fast
MDedge Family Medicine
AAP cautions against marijuana use during pregnancy, breastfeeding
MDedge Family Medicine
Eat/sleep/console approach almost eliminates morphine for NAS
MDedge Family Medicine
Pertussis vaccine at birth shows immune response, tolerability
MDedge Family Medicine
How to screen for, manage FASD in a medical home
MDedge Family Medicine
Congenital syphilis rates continue skyrocketing alongside other STDs
MDedge Family Medicine